News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
219,621 Results
Type
Article (4981)
Company Profile (20)
Press Release (214620)
Section
Business (82139)
Career Advice (459)
Deals (15052)
Drug Delivery (8)
Drug Development (19047)
Employer Resources (30)
FDA (3684)
Job Trends (3894)
News (120006)
Policy (7525)
Tag
Academia (294)
Africa (181)
Alabama (12)
Alliances (14708)
Alzheimer's disease (199)
Approvals (3672)
Arizona (40)
Asia (11239)
Australia (1532)
Bankruptcy (93)
Best Places to Work (2789)
Biotechnology (18)
C2C Services and Suppliers (25471)
California (525)
Canada (302)
Cancer (79)
Career advice (390)
Cell therapy (22)
China (17)
Clinical research (15408)
Collaboration (21)
Colorado (15)
Compensation (20)
Connecticut (21)
COVID-19 (286)
Cystic fibrosis (10)
Data (59)
Diagnostics (1956)
Diversity, equity & inclusion (12)
Earnings (39353)
Employer resources (30)
Europe (23670)
Events (36465)
Executive appointments (50)
FDA (3719)
Florida (67)
Funding (20)
GLP-1 (86)
Government (409)
Healthcare (4996)
Hotbed/Location (163470)
Idaho (23)
Illinois (57)
Indiana (27)
Infectious disease (288)
Inflammatory bowel disease (19)
Interviews (53)
IPO (7707)
Job creations (1118)
Job search strategy (360)
Kansas (23)
Layoffs (94)
Legal (2321)
Liver cancer (14)
Lung cancer (13)
Maine (31)
Maryland (75)
Massachusetts (480)
Medical device (3787)
Medtech (3788)
Mergers & acquisitions (7314)
Metabolic disorders (28)
Michigan (46)
Minnesota (84)
Montana (16)
Nebraska (12)
Neuroscience (215)
New Hampshire (13)
New Jersey (185)
New York (197)
NextGen Class of 2024 (1677)
Non-profit (723)
North Carolina (208)
Northern California (267)
Obesity (20)
Ohio (25)
Opinion (27)
Pennsylvania (131)
People (23952)
Phase I (4576)
Phase II (6697)
Phase III (5332)
Pipeline (71)
Postmarket research (625)
Preclinical (1797)
Press Release (66)
Rare diseases (19)
Real estate (1870)
Regulatory (4932)
Reports (13)
Research institute (297)
Resumes & cover letters (68)
South America (273)
Southern California (201)
Startups (1005)
Texas (60)
United States (2439)
Utah (16)
Vaccines (17)
Washington State (50)
Date
Last 7 days (178)
Last 30 days (653)
Last 365 days (11750)
2024 (8035)
2023 (13213)
2022 (18680)
2021 (19701)
2020 (18269)
2019 (13252)
2018 (10229)
2017 (10021)
2016 (9183)
2015 (12152)
2014 (9605)
2013 (7742)
2012 (8359)
2011 (8832)
2010 (8653)
219,621 Results for "idt biologika corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Valneva and IDT Biologika Agree on Termination of their COVID-19 Collaboration
ValnevaSE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and IDT Biologika today announced they have agreed to terminate their collaboration following the delivery of inactivated COVID-19 bulk vaccine to Valneva, and considering the current order levels and existing inventories.
September 16, 2022
·
6 min read
IDT Biologika collaborates with Exothera to push forward the scale-up of viral vaccines
IDT Biologika, a leading Contract Development and Manufacturing Organization specialized in vaccines, gene and immune therapy and oncolytic viruses based in Germany, and Exothera S.A. collaborate to develop a large-scale manufacturing process for viral vector-based vaccines.
March 1, 2022
·
2 min read
Business
Integrated DNA Technologies and Molecular Health Ink Commercial Partnership
Genomics solutions provider Integrated DNA Technologies (IDT) and Bio-IT company Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their next generation sequencing (NGS) capabilities.
May 15, 2024
·
6 min read
Scitara and IDT present a composable IT architecture platform at Lab of The Future Europe 2023
Innovator in laboratory digital transformation and leading global provider of cloud-based solutions for science, Scitara, presents its Digital Lab Exchange DLX™ platform
October 4, 2023
·
2 min read
Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine
Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced a mutual agreement with IDT Biologika GmbH (“IDT”), a contract development and manufacturing organization, to utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate (TAK-003) to manufacture the single-shot COVID-19 vaccine
March 15, 2021
·
9 min read
BioCapital
IDT Biologika Receives Six 2019 CMO Leadership Awards
IDT Biologika, a globally integrated contract manufacturer of vaccines and biopharmaceuticals, honored with six 2019 CMO Leadership Awards in all categories, including Capabilities, Compatibility, Expertise, Quality, Reliability and Service.
March 26, 2019
·
4 min read
Policy
IDT Biologika Awarded New Task Order in the Scope of 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases
IDT Biologika announced that the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, an agency of the United States Department of Health and Human Services, has awarded the company a new Task Order within the 10-year Indefinite Delivery, Indefinite Quantity contract no. HHSN272201800011I to provide process development activities and production of a vaccine against the Respiratory Syncytial Virus.
November 5, 2019
·
3 min read
Business
Integrated DNA Technologies and Element Biosciences Accelerate Next Generation Sequencing Workflows for Element’s AVITI™ System
Life sciences companies Integrated DNA Technologies (IDT) and Element Biosciences, Inc. have bolstered their partnership with products to enable more efficient and streamlined next generation sequencing (NGS) workflows for users of the AVITI System, an innovative sequencing and multi-omics platform based on Element’s novel avidity base chemistry.
February 5, 2024
·
5 min read
Policy
IDT Biologika Awarded with a Task Order Within 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases
IDT Biologika announced that the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, an agency of the United States Department of Health and Human Services, has awarded the company a new Task Order within the 10-year Indefinite Delivery, Indefinite Quantity contract no.
July 10, 2019
·
2 min read
Deals
Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.
May 28, 2024
·
9 min read
1 of 21,963
Next